Global Nitinol Medical Devices Market: Segment Snapshot and Table of Content (2017-2025)

Global Nitinol Medical Devices Market: Players take the Mergers and Acquisitions Route to Expand Outreach, finds TMR

As per a report by TMR, the global nitinol medical devices market is anticipated to clock a CAGR of 8.2% between 2017 and 2025 for the market to reach a valuation of US$25,657.5 mn by 2025-end. The market was evaluated at US$12,783.9 mn in 2016.

The Global Nitinol Medical Devices Market is segmented on the basis of Product, Application, Geography.

Based on application, the key segments include orthopedic, vascular, dental, gastroenterology, and others. The vascular segment held the leading market share of more than 60% in 2016 in the global nitinol medical devices market. This is mainly because of rising prevalence of cardiovascular diseases and increasing adoption of nitinol based stents for vascular surgeries.

Read Report Overview @ https://www.transparencymarketresearch.com/nitinol-medical-devices.html

Based on end-user, the report classifies the global nitinol medical devices market into hospitals, clinics, ambulatory surgical centers, and others. In 2016, hospitals led the market and the trend is anticipated to continue over the forecast period. The growth of hospitals segment is attributed to the increasing demand for minimally invasive surgeries and increasing number of surgeries for vascular and orthopedic diseases. However, clinics and ambulatory surgical centers segments are anticipated to surpass in terms of growth rate over the forecast period due to surging demand for same-day surgeries.

Based on region, the nitinol medical devices market has been classified into North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. North America accounted for the leading market share vis-à-vis revenue in 2016 due to increasing adoption of technologically advanced products and increasing prevalence of peripheral artery disease. As per statistics of the Houston Methodist Research Institute, peripheral arterial disease affects 13% to14% of the elderly population in the U.S. Further, prevalence of peripheral artery disease, which increases with age, can also range from 13% to 32% among individuals of 80 years of age.

Request Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1685

Powered by the U.K, Germany, and France Europe is a key market for nitinol medical devices. As per the European Heart Network, cardiovascular diseases are responsible for 3.9 million deaths each year in Europe. In 2015, 11.3 million new cases of cardiovascular diseases were reported in Europe.

Summary of Table of Content

1. Preface
2. Assumptions and Research Methodology
3. Executive Summary
4. Market Overview
5. Market Dynamic
6. Global Nitinol Medical Devices Market Analysis, by Product
7. Nitinol Medical Devices Market Analysis, by Application
8. Nitinol Medical Devices Market Analysis, by End-user
9. Global Nitinol Medical Devices Market Analysis, by Region
10. North America Nitinol Medical Devices Market Analysis
11. Europe Nitinol Medical Devices Market Analysis
12. Asia Pacific Nitinol Medical Devices Market Analysis
13. Latin America Nitinol Medical Devices Market Analysis
14. Middle East & Africa Nitinol Medical Devices Market Analysis
15. Company Profiles

Request to Browse Full Table of Content, figure and Tables @ https://www.transparencymarketresearch.com/report-toc/1685

ABOUT US:
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

CONTACT:
Transparency Market Research
State Tower
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-345

This release was published on openPR.